However, allantoin administration in MCD mice significantly increased ACAT1 compared with the NASH group (642.85±4.70vs 0.93±0.05, P<0.001) (Figure 5). This evidence concerns the gene ACAT1 and metabolic dysfunction-associated steatohepatitis.